Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

19.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.4K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

63
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
63

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Musculo-Tendinous Changes in Spastic Plantar-Flexor Muscles After Spinal Cord Injury.

Archives of physical medicine and rehabilitation·2026
Same author

Prognostic Impact of Baseline Neutrophil-to-Lymphocyte Ratio and Its On-Treatment Change on Survival Outcomes in Advanced Small-Cell Lung Cancer: A Retrospective Analysis.

Cancers·2026
Same author

Atrial TRPM2 Channel-Mediated Ca<sup>2+</sup> Influx Regulates ANP Secretion and Protects Against Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis.

Cells·2026
Same author

Anillin actin-binding protein expression correlates with poor prognosis for prostate cancer patients.

Asian journal of urology·2024
Same author

Dynamic remodeling of TRPC5 channel-caveolin-1-eNOS protein assembly potentiates the positive feedback interaction between Ca<sup>2+</sup> and NO signals.

The Journal of biological chemistry·2024
Same author

Mouse transient receptor potential melastatin 2 (TRPM2) isoform 7 attenuates full-length mouse TRPM2 activity through reductions in its expression by targeting it to ER-associated degradation.

Genes to cells : devoted to molecular & cellular mechanisms·2024

Related Experiment Video

Updated: Mar 15, 2026

Quantification of Reactive Oxygen Species Using 2&#8242;,7&#8242;-Dichlorofluorescein Diacetate Probe and Flow-Cytometry in M&#252;ller Glial Cells
14:25

Quantification of Reactive Oxygen Species Using 2′,7′-Dichlorofluorescein Diacetate Probe and Flow-Cytometry in Müller Glial Cells

Published on: May 13, 2022

7.9K

Targeting TRPM2 in ROS-Coupled Diseases.

Shinichiro Yamamoto1, Shunichi Shimizu2

  • 1Division of Pharmacology, Faculty of Pharmaceutical Sciences, Teikyo Heisei University, Tokyo 164-8530, Japan. s.yamamoto@thu.ac.jp.

Pharmaceuticals (Basel, Switzerland)
|September 13, 2016
PubMed
Summary

Reactive oxygen species (ROS) drive disease. TRPM2 channels link ROS to calcium signaling, exacerbating inflammation and other ROS-related conditions.

Keywords:
Ca2+ signalingROS-coupled diseasesTRPM2reactive oxygen species

More Related Videos

Production and Detection of Reactive Oxygen Species ROS in Cancers
07:17

Production and Detection of Reactive Oxygen Species ROS in Cancers

Published on: November 21, 2011

71.2K
Stimulation of Stem Cell Niches and Tissue Regeneration in Mouse Skin by Switchable Protoporphyrin IX-Dependent Photogeneration of Reactive Oxygen Species In Situ
10:05

Stimulation of Stem Cell Niches and Tissue Regeneration in Mouse Skin by Switchable Protoporphyrin IX-Dependent Photogeneration of Reactive Oxygen Species In Situ

Published on: May 8, 2020

2.3K

Related Experiment Videos

Last Updated: Mar 15, 2026

Quantification of Reactive Oxygen Species Using 2&#8242;,7&#8242;-Dichlorofluorescein Diacetate Probe and Flow-Cytometry in M&#252;ller Glial Cells
14:25

Quantification of Reactive Oxygen Species Using 2′,7′-Dichlorofluorescein Diacetate Probe and Flow-Cytometry in Müller Glial Cells

Published on: May 13, 2022

7.9K
Production and Detection of Reactive Oxygen Species ROS in Cancers
07:17

Production and Detection of Reactive Oxygen Species ROS in Cancers

Published on: November 21, 2011

71.2K
Stimulation of Stem Cell Niches and Tissue Regeneration in Mouse Skin by Switchable Protoporphyrin IX-Dependent Photogeneration of Reactive Oxygen Species In Situ
10:05

Stimulation of Stem Cell Niches and Tissue Regeneration in Mouse Skin by Switchable Protoporphyrin IX-Dependent Photogeneration of Reactive Oxygen Species In Situ

Published on: May 8, 2020

2.3K

Area of Science:

  • Biomedical science
  • Molecular biology
  • Pathophysiology

Background:

  • Pathological conditions like inflammation and ischemia-reperfusion injury generate reactive oxygen species (ROS).
  • ROS contribute significantly to disease development and severity.
  • TRPM2 channels are implicated in various ROS-associated diseases.

Purpose of the Study:

  • To review the role of TRPM2 channels in converting oxidative stress into calcium (Ca2+) signaling.
  • To highlight TRPM2's function as a molecular link between ROS and Ca2+ signaling in disease.

Main Methods:

  • Literature review focusing on TRPM2 channel function.
  • Analysis of TRPM2's role in ROS-mediated cellular processes.
  • Examination of TRPM2's involvement in inflammatory and other ROS-coupled diseases.

Main Results:

  • TRPM2 channels are activated by ROS in an ADP-ribose-dependent manner.
  • TRPM2 acts as a transducer, converting oxidative stress into Ca2+ signals.
  • TRPM2-mediated Ca2+ influx in monocytes exacerbates inflammation through chemokine production.

Conclusions:

  • TRPM2 is a key molecular player linking ROS to Ca2+ signaling.
  • Understanding TRPM2's role is crucial for developing therapeutic strategies for ROS-coupled diseases.
  • TRPM2 channel modulation may offer a target for treating inflammatory and other oxidative stress-related pathologies.